Chiesi gets first-ever European stem cell nod

December 19, 2014
Sales and Marketing Chiese, Chiesi, EMA, Holoclar, LSCD, MHRA, Stem cells, orexigen

Chiesi has received the first approval for an advanced therapy medicinal product containing stem cells for use in Europe. The …

Ian Goldin, director, Oxford Martin School, University of Oxford speaks at the c

Visions for the future: FT pharma and biotech event

December 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, ABPI, Deloitte, Medidata, Whitehead, financial ties, freeman, ft pharma

The FT Global Pharmaceutical and Biotechnology Conference held in London recently asked: “What will the life science company of the …

Merck image

Merck acquires Swiss firm OncoEthix

December 19, 2014
Sales and Marketing Cancer, FDA, Merck, OTX015, cubist, keytruda, oncoethix, pembrolizumab

Hot on the heals of its Cubist buyout Merck has confirmed the acquisition of OncoEthix, a Swiss based firm which …

Roche image

Roche dealt with two late-stage blows

December 19, 2014
Sales and Marketing Alzheimer's, Alzheimer’s, Cancer, Kadcyla, Perjeta, Roche, Xeloda, trastuzumab emtansine

Swiss giant Roche’s breast cancer treatment Kadcyla has failed to meet its primary endpoint and its investigational Alzheimer’s treatment trial …

GSK image

GSK shingles vaccine on form

December 19, 2014
Sales and Marketing GSK, HZ/su, Merck, Vaccine, Zostavax, shingles

GlaxoSmithKline will be celebrating following the successful Phase III study of its shingles vaccine HZ/su that has met its primary …

NHS not au fait with mobile-savvy patients

December 19, 2014
Medical Communications, Sales and Marketing NHS, app, digital, health, mobile, smartphones, wearables

The NHS is failing to keep up with its digital generation of patients, a recent study has found.  Despite a …

andrew_plump_takeda

Takeda takes senior head from Sanofi

December 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Takeda, andrew plump

Dr Andrew Plump will be joining Takeda in February from Sanofi to lead its global R&D operations as chief medical …

Pfizer image

New Lyrica formulation effective in trials

December 19, 2014
Sales and Marketing HIV, Lyrica, Pfizer, pain, pregabalin, shingles

Pfizer has reported positive Phase III results for a new formulation of its painkiller Lyrica. In the study, a controlled-release …

Humira biosimilar released in India

December 18, 2014
Research and Development, Sales and Marketing Humira, India, Zydus Cadila, anti-inflammatory, arthritis, bioscience

Indian firm Zydus Cadila has launched the first biosimilar of AbbVie’s anti-inflammatory medicine Humira, the world’s biggest-selling drug. Used as …

Government plans £6 billion precision medicine strategy

December 18, 2014
Research and Development, Sales and Marketing ABPI, Cell Therapy Catapult, Ebola, George Osborne, UK, government

The government has committed to a £6 billion investment in scientific research and development as part of its science and …

Lundbeck scraps stroke drug

December 18, 2014
Research and Development, Sales and Marketing AIS, DIAS, Lundbeck, acute ischemic stroke, desmoteplase, stroke

Lundbeck has stopped development of its investigational stroke drug desmoteplase following disappointing results from its Phase III studies. The DIAS-3 …

Astrazeneca image

AstraZeneca ovarian cancer drug approved in Europe

December 18, 2014
Sales and Marketing AstraZeneca, BRCA, Cambridge, Cancer, FDA, lynparza, olaparib, ovarian

The European Commission has approved AstraZeneca’s Lynparza for the treatment of advanced BRCA-mutated ovarian cancer. Lynparza (olaparib) has been approved …

bernard_poussot_roche

Roche adds two to its board

December 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernard Poussot, Richard Lift, Roche, Sanofi

Roche intends to grow at its March annual general meeting via the election of Bernard Poussot and Richard Lift who …

Roche wins drug discovery award for Gazyvaro

December 18, 2014
Sales and Marketing BPS, British Pharmacological Society, GSK, Gazyvaro, Roche, mekinist

Roche has been named the winner of the 2015 Drug Discover of the Year award by the British Pharmacological Society …

Janssen Healthcare Innovation two-time finalists at eyeforpharma Barcelona Awards

December 17, 2014

Janssen Healthcare Innovation’s Care4Today programme is set to take two of the highest honours at the 2015 eyeforpharma Barcelona Awards …

PM Society names pharma prize finalists

December 17, 2014
Medical Communications, Sales and Marketing GSK, Mundipharma, Shire, VCCP Health, digital awards, pm society

The finalists for the PM Society Awards have been announced today as pharma and med comms agencies gear up to …

Cyramza  image

Lilly’s lung cancer drug sees FDA approval

December 17, 2014
Sales and Marketing BMS, Cancer, FDA, NSCLC, cyramza, docetaxel, lilly, opdivo, ramucirumab

Eli Lilly’s lung cancer drug Cyramza (ramucirumab) has been shown the green light by the US Food and Drug Administration …

Apps & Digital Resources vie for top honour at eyeforpharma Barcelona Awards

December 17, 2014

Two thirds of the finalists for the ‘Most Valuable Patient Initiative’ in the 2015 eyeforpharma Barcelona Awards have used interactive …

research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014
Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …

EMA image

Adaptive licensing could ‘transform industry’

December 17, 2014
Research and Development, Sales and Marketing Clinical Pharmacology & Therapeutics, EFPIA, EMA, MHRA, adaptive licesning

Drug regulators should switch to adaptive pathways as the preferred approach to bringing future new medicines to patients, according to …

The Gateway to Local Adoption Series

Latest content